Skip to search formSkip to main contentSkip to account menu

Desogestrel

Known as: 13-Ethyl-11-methylene-18,19-dinor-17 alpha-pregn-4-en-20-yn-17-ol, 13 Ethyl 11 methylene 18,19 dinor 17 alpha pregn 4 en 20 yn 17 ol, Desogestrel [Chemical/Ingredient] 
A synthetic progestogen structurally related to levonorgestrel, with progesterone hormone receptor agonistic activity, used as a contraceptive and… 
National Institutes of Health

Related topics

Related topics

42 relations
Acne VulgarisCerebrovascular DisordersCoronary heart diseaseDesogestrel / Ethinyl Estradiol

Narrower (11)

CTR 24CerazetteDesogen (contraceptive)Etonogestrel

Broader (1)

Progestins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2001
Highly Cited
2001
Original research article Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel
Desogestrel (DSG) is a less-androgenic progestogen than levonorgestrel (LNG). This difference in androgenicity may be responsible… 
2000
2000
Preclinical experience with two selective progesterone receptor modulators on breast and endometrium
1999
1999
Effect on stroke of different progestagens in low oestrogen dose oral contraceptives
1995
1995
Ovarian function during low-dose oral contraceptive use.
Review
1994
Review
1994
Hormonal implants: Contraception for a new century
1993
1993
Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17 beta-estradiol.
1991
1991
Progestogens: therapeutic and adverse effects in early post-menopausal women.
Review
1990
Review
1990
Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid.
Highly Cited
1985
Highly Cited
1985
A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins.
Highly Cited
1982
Highly Cited
1982
Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)